Bortezomib
purity 99%
Cas No.:179324-69-7
high quality and competitive price

1.Product: Bortezomib

2.CAS NO.: 179324-69-7

3.M.F.:   C19H25BN4O4                                

4.M.W.:  384.2372

5.Appearance: white or almost white powder

6.Spec.:     Injection

7.Usage: to treat multiple myeloma

Bortezomib  is the first therapeutic proteasome inhibitor to be tested in humans. It is approved in the U.S. for treating relapsed multiple myeloma and mantle cell lymphoma. In multiple myeloma, complete clinical responses have been obtained in patients with otherwise refractory or rapidly advancing disease.